Check out your Company Bowl for anonymous work chats.
We’re pleased to share that MM+M - Medical Marketing and Media has included Chumi Khurana, Senior Vice President and U.S. Oncology Franchise Head, in their 2026 class of Women of Distinction! MM+M’s Women of Distinction and Women to Watch program celebrates healthcare leaders who are making a positive impact on their company and industry. We are grateful and proud to have Chumi leading our oncology team to address the unmet needs of people living with rare cancers. Her dedication is an integral part of our work to make a difference for patients who urgently need better answers and to transform the lives of patients and their families.
We're pleased to share that MM+M - Medical Marketing and Media has included Chumi Khurana, Senior Vice President and U.S. Oncology Franchise Head, in their 2026 class of Women of Distinction! MM+M's... | Jazz Pharmaceuticals | 65 comments
Our teams got to celebrate our recent honor of receiving the Gold Stevie Award at the 2025 National Sales Network Conference & Career Fair. We had a great time networking with fellow industry innovators and sharing our ongoing efforts to create a workplace environment where employees can thrive, while delivering on our purpose to innovate to transform the lives of patients and their families.
Stevie Award 2025 | Jazz Pharmaceuticals
Jazz Remix isn't just about where we work, it's about how we work. By providing employees flexibility, we empower our teams to achieve better work-life integration, leading to increased productivity and a stronger focus on our purpose to innovate to transform patients' lives. Click to learn more about the Jazz Remix model.
Fueling Innovation Through Jazz Remix and the Employee Experience
To promote collaboration as part of our Jazz Remix flexible working model, we’ve introduced Connection Days. These quarterly touchpoints help us maintain a strong sense of community and deepen connections with colleagues. At a recent Connection Day, we strengthened our vibrant culture by engaging in team-oriented volunteer activities and networking opportunities. We believe that a collaborative work environment is key to driving innovation and meaningful science for patients and their families and we are proud to give back when we come together driving social impact in our local communities. Ready for your next career opportunity? Explore open roles with us today: http://bit.ly/3TIpP96
To promote collaboration as part of our Jazz Remix flexible working model, we've introduced Connection Days. | Jazz Pharmaceuticals
We’re pleased to announce that the Jazz Board of Directors has unanimously selected Renée Galá, as President and CEO effective August 11. Currently, Jazz’s President and Chief Operating Officer, she brings 30 years of experience across finance, strategy, corporate development and commercialization along with a deep commitment to patients. Find more information here: http://bit.ly/3IicaTF
We're pleased to announce that the Jazz Board of Directors has unanimously selected Renée Galá, as President and CEO effective August 11. | Jazz Pharmaceuticals
Building on the awareness generated from TSC Global Day, we remain committed to partnering with organizations like the TSC Alliance to provide a deeper understanding of challenging and complex neurological conditions like Tuberous Sclerosis Complex (TSC) and to help provide much-needed resources for these communities. Learn more here: https://bit.ly/3YcLtVO
#tscglobalday #tuberoussclerosiscomplex | Jazz Pharmaceuticals
Last month, members of our team were honored to gather in Washington, D.C. to support the Epilepsy Foundation at their National Epilepsy Walk. This annual event helps drive much-needed awareness for the approximately 50 million people living with hashtag#epilepsy worldwide. Through our ongoing research advancements, we remain dedicated to developing treatment options to help address the unmet needs of those living with this challenging disease. Learn more about our commitment: https://bit.ly/3YcLtVO
#epilepsy | Jazz Pharmaceuticals
We’re pleased to announce we have completed the acquisition of Chimerix, strengthening our presence in the rare oncology space and reinforcing our commitment to people living with rare diseases with significant unmet need. Find more information here: https://bit.ly/3Er2RiR
#oncology | Jazz Pharmaceuticals | 12 comments
From day one, we have been driven by our people and our purpose. Now, 20 years later, that commitment continues with Jazz Remix, our flexible working model. Learn more from Chief People Officer, Heidi Manna, as she shares how Jazz Remix empowers our employees to thrive and ultimately better serve patients: https://lnkd.in/efi_6-CJ
Fueling Innovation Through Jazz Remix and the Employee Experience
In recognition of hashtag#LungCancerAwarenessMonth and hashtag#NationalFamilyCaregivingMonth, we’re sharing Ed’s story and his experience with small cell lung cancer (hashtag#SCLC). With the support of his daughter and a dedicated care team, Ed continues to demonstrate resilience and courage every day and finds strength in keeping a positive attitude. Read more about Ed’s journey: https://bit.ly/40LSUVQ We recognize that those living with SCLC and other difficult diagnoses face many challenges, which is why we’re working to redefine what is possible in the treatment of cancer to improve the lives of patients.
Jazz Pharmaceuticals on LinkedIn: #lungcancerawarenessmonth #nationalfamilycaregivingmonth #sclc